results
Last reviewed 01/2018
The trial was terminated early because of highly significant reduction in mortality in the poractant alfa group.
Mortality data was analysed for 199 neonates:
- in the Porcactant alpha group mortality was 14.1%
- in the Pumactant group mortality was 31%
- p=0.006